Oriented Collagen Biocomposite Scaffold for Tendon Repair

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for repairing tendons and ligaments are limited by the mechanical weakness of collagen-based scaffolds, which lead to poor tissue integration and high failure rates due to enzymatic degradation, immune reactions, and wear debris, and lack the necessary strength and elasticity to support tissue function effectively.

Innovation Solution

The development of oriented collagen-based biocomposite materials and structures, formed through methods that align collagen fibrils in specific patterns and cross-link them to enhance strength, and treat them with factors like heparin to improve hydration and growth factor storage, creating a scaffold that mimics natural tendon and ligament structures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If collagen-based scaffolds are used for tendon and ligament repair, then cell attachment and migration are improved, but mechanical strength is insufficient leading to high failure rates

Engineering Contradiction:
Improvetissue integration successVSAvoidmechanical strength
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The patent combines collagen with other materials (such as synthetic polymers, ceramics, or cross-linking agents) to create composite scaffolds that maintain the biocompatibility and cell-friendly properties of collagen while adding mechanical strength and structural stability from the complementary materials

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent modifies physical and chemical parameters of collagen including cross-linking density, molecular weight, concentration, and processing conditions to optimize both mechanical properties and biological functionality, transforming collagen from a weak gel structure to a strength-enhanced scaffold

Inventive Principle:
Principle #35Parameter changes

2Reliability

If collagen is used in pure form, then biocompatibility is improved, but structural organization is lost limiting medical applications

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidstructural organization
Core Design Contradiction:
ReliabilityVSShape

Solution Approach 1:

The patent pre-organizes collagen molecules into fibrillar structures, aligns them in specific patterns, or creates hierarchical architectures before implantation to restore the structural organization found in native tissues, enabling the scaffold to mimic natural tendon and ligament architecture

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent creates spatially varying properties within the collagen scaffold, such as regions with different fiber densities, orientations, or compositions tailored to specific functional requirements of different tissue zones, reproducing the heterogeneity of native extracellular matrix

Inventive Principle:
Principle #3Local quality

3Ease of manufacture

If collagen scaffolds lack cross-linking, then ease of manufacture is improved, but enzymatic degradation increases leading to poor tissue integration

Engineering Contradiction:
Improvescaffold fabricationVSAvoidscaffold stability
Core Design Contradiction:
Ease of manufactureVSDuration of action of stationary object

Solution Approach 1:

The patent applies controlled cross-linking treatments that modify the chemical parameters of collagen by forming covalent bonds between molecules, thereby enhancing structural stability and resistance to enzymatic degradation while maintaining manufacturability through established cross-linking methodologies

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The resulting biocomposite materials provide enhanced mechanical strength, improved cell attachment and migration, and sustained delivery of growth factors, leading to more effective tissue repair and regeneration by creating a scaffold that closely resembles native tissue structures.

Implementation Method 1

flowing the fibrillar biopolymer solution or gel in a substantially laminar flow regime or manner

Methodology Applied
Scientific EffectLaminar flow: Laminar Flow

Implementation Method 2

transforming the fibrillar biopolymer solution or gel from a liquid to solid phase to form an oriented fibrillar biopolymer material

Methodology Applied
Scientific EffectEvaporation: Evaporation

Implementation Method 3

cross-link them to enhance strength

Methodology Applied
Scientific EffectCross-linking: Chemical Bonding

Data Source

PatentUS11013826B2Biocomposites and methods of making the same
Publication Date: 2021.05.25 FIBRALIGN CORP
  • US11013826B2 patent drawing
  • US11013826B2 patent drawing
  • US11013826B2 patent drawing

AI summary

In general, the present invention is related to biopolymer and biocomposite materials and structures, and methods of making and using the same. In some embodiments, the present invention is directed to oriented collagen based biocomposite materials and structures, and methods of making.